Disclosure 0001855980-26-000009-1

SEC FORM 4

—

Iambic Therapeutics, Inc. (IAM)

Acquisition (code C) of 61,342 shares; price not stated (see filing).

Reporting Person Secora Michael · Officer Title CFO & Chief Corp Dev Ofcr · Transaction Code C

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001855980-26-000009 · filed 2026-10-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Iambic Therapeutics, Inc. (IAM)." Disclosed 2026-10-19. https://desqlong.com/cards/0001855980-26-000009-1 (retrieved 2026-10-20).